EVOTEC AND APEIRON BIOLOGICS TO DISCOVER NOVEL PAIN THERAPEUTICS

Evotec AG and Apeiron Biologics GmbH today announced that they have entered into a discovery collaboration to develop small molecules targeting a novel therapeutic concept for pain relief. This concept is based on research activities of Prof Josef Penninger, Director of the Institute for Molecular Biotechnology of the Austrian Academy of Sciences (IMBA).
WebWire